IMPURITIES AVAILABLE FOR 'Carfilzomib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Carfilzomib. Carfilzomib is a second-generation proteasome inhibitor used in the treatment of multiple myeloma. It works by irreversibly binding to the chymotrypsin-like activity of the 20S proteasome, leading to the accumulation of misfolded proteins and induction of apoptosis in malignant plasma cells. Carfilzomib is administered intravenously, often in combination with other agents such as lenalidomide and dexamethasone, to enhance therapeutic efficacy. Compared to bortezomib, it demonstrates improved specificity and reduced risk of peripheral neuropathy. Common side effects include fatigue, anemia, thrombocytopenia, diarrhea, and nausea. Serious adverse effects may include cardiac complications, hypertension, and infusion-related reactions, requiring careful monitoring. Carfilzomib has shown significant clinical benefits in relapsed and refractory multiple myeloma patients. Its targeted mechanism and improved safety profile make it an important option in modern cancer therapy. Buy high quality Carfilzomib from Omsynth Lifesciences.

Total Products : 15 (Page 1 of 1)
CAT No. : OM_2698
CAS No : 1541172-75-1
More Details Enquire
CAT No. : OM_2699
CAS No : 1672698-96-2
More Details Enquire

We Make Every Effort To Be A Responsible Business

As our expectations evolve, we seek to meet new and emerging challenges that present themselves.

Help Desk 24/7

+91-9028243601